Treatment of 1,25(OH)2D3 (D-hormone) deficiency/resistance with D-hormone and analogs

Osteologie

Volumn 10, Issue 1, 2001, Pages 28-39

  Lau, K H W ^a   Baylink, D J ^a  

^a Jerry L Pettis V A Medical Center   (United States)

Author keywords

D hormone; D hormone deficiency; D hormone resistance; Senile osteoporosis

Indexed keywords

CALCITRIOL; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR BETA;

AGING; BONE ATROPHY; CALCIUM ABSORPTION; DISEASE ASSOCIATION; FALLING; FRACTURE; HORMONE ACTION; HORMONE RESISTANCE; HUMAN; INTESTINE ABSORPTION; MUSCLE STRENGTH; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; PATHOGENESIS; REVIEW; RISK FACTOR; SECONDARY HYPERPARATHYROIDISM; VITAMIN D DEFICIENCY;

EID: 0034990597     PISSN: 10191291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (90)

1. Ca absorption in postmenopausal osteoporosis
2. Effect of age on calcium absorption
3. Markers of bone remodeling in the elderly subject: Effects of vitamin D insufficiency and its correction
4. Local action of oral 1,25 dihydroxycholecalciferol on calcium absorption in osteoporosis
5. The decline in vitamin D status with age
6. Impaired vitamin D metabolism with aging in women: Possible role in pathogenesis of senile osteoporosis
7. Histomorphometric profile and vitamin D status in patients with femoral neck fracture
8. Annual injection of vitamin D and fractures in aged bones
9. Influence of vitamin D on parathyroid function in the elderly
10. Hypovitaminosis D in medical inpatients
11. Vitamin D deficiency in welfare institutions for the aged
12. Differences in vitamin D status between countries in young adults and the elderly
13. Vitamin D status and sex hormone-binding globulin: Determinants of bone turnover and bone mineral density in elderly woman
14. Bone density, parathyroid hormone and 25-hydroxyvitamin D concentrations in middle-aged women
15. 3 and calcium to prevent hip fractures in the elderly women
16. 2D
17. Endogenous hormones and the risk of hip and vertebral fractures among older women
18. The influence of age on bone mineral regulating hormones
19. Interrelationship among vitamin D metabolism, true calcium absorption, parathyroid function, and age in women: Evidence of an age-related intestinal resistance to 1,25-dihdroxyvitamin D action
20. Effect of parathyroid hormone (hPTH[1-34]) infusion on serum 1,25-dihydroxyvitamin D and parathyroid hormone in normal women
21. Renal impairment and its effects on calcium metabolism in elderly women
22. Renal 1,25-dihydroxyvitamin D, phosphaturic, and cyclic-AMP responses to intravenous synthetic human parathyroid hormone (1.-34) administration in normal subjects
23. The pathogenesis of age-related osteoporotic fracture: Effects of dietary calcium deprivation
24. The need for more vitamin D
25. Deficient production of 1,25-dihydroxyvitamin D in elderly osteoporotic patients
26. Evidence of an age-related decrease in intestinal responsiveness to vitamin D: Relationship between serum 1,25-dihydroxyvitamin D and intestinal vitamin D receptor concentration in normal women
27. 125-Dihydroxyvitamin D. in normal subjects and in patients with postmenopausal osteopenia. Influence of age, renal function and oestrogen therapy
28. 2 in elderly subjects
29. Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. A role for increased sensitivity to calcium
30. Vitamin D deficiency causes a selective reduction in deposition of transforming growth factor β in rat bone: Possible mechanism for impaired osteoinduction
31. The 24/25kDa serum insulin-like growth factor binding proteinis increased in elderly women with hip and spine fractures
32. 3 differentially regulates the production of IGF-I and IGFBP-4 in mouse osteoblasts
33. Age-related decreases in insulin-like growth factor-I and transforming growth factor-β in femoral cortical bone from both men and women: Implications for bone loss with aging
34. Aging-associated decline in human femoral neck cortical and trabecular content of insulin-like growth factor I: Potential implications for age-related (type II) osteoporotic fracture occurrence
35. Muscle strength in the elderly: Its relation to vitamin D metabolites
36. Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement
37. Severe myopathy associated with vitamin D deficiency in western New York
38. Calcium absorption in the elderly
39. Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients. Effect of age and dietary calcium
40. Calcium absorption in women: Relationship to calcium intake, estrogen status and age
41. Influence of age on effects of endogenous 1,25-dihydroxyvitamin D on calcium absorption in normal women
42. A comparison of the effects of alfacalcidol treatment and vitamin D supplementation on calcium absorption in elderly women with vertebral fractures
43. Serum vitamin D metabolites and calcium absorption in normal young and elderly free-living women and in women living in nursing homes
44. Serum intact parathyroid hormone in a random population sample of men and women: Relationship to anthropometry, life-style factors, blood pressure and vitamin D
45. 3
46. Assessment of biochemical markers of bone metabolism in relation to the occurrence of fracture: A retrospective and prospective population-based study of women
47. Differences in bone resorption after menopause in Japanese women with normal or low bone mineral density: Quantitation of urinary cross-linked N-telopeptides
48. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis
49. Decreased bone formation and mineralization, and enhanced resorption in calcium-deficient rats
50. Muscle strength and speed of movement in relation to age and muscle morphology
51. Age-related differences in knee muscle strength in normal women
52. Muscle morphology enzymatic activity and muscle strength in elderly men: A follow-up study
53. Risk factors for hip fracture in white women
54. Type of fall and risk of hip and wrist fractures: The study of osteoporotic fractures
55. Prediction of osteoporotic fractures by postural instability and bone density
56. Relation between bone mineral density of spine and strength of back extensors in health of postmenopausal women
57. 3 receptors and activities in muscle
58. 3 receptors and hormonal responses in cloned human skeletal muscle cells
59. 25-Hydroxycholecalciferol stimulation of muscle metabolism
60. Effect of vitamin D deficiency on sarcoplasmic reticulum function and troponin C concentration of rabbit skeletal muscle
61. Muscular weakness in osteomalacia and hyperparathyroidism
62. Role of vitamin D in skeletal muscle function
63. Low serum calcidiol concentration in older adults with reduced muscular function
64. Muscle strength in healthy White and Asian subjects: The relationship of quadriceps maximum voluntary contraction to age, sex, body build and vitamin D
65. Vitamin D deficiency and muscle strength in male alcoholics
66. Relationship between age-associated endocrine deficiencies and muscle function in elderly women: A cross-section study
67. Quadriceps and grip strength are related to vitamin D receptor genotype in elderly nonobese women
68. Vitamin D receptor polymorphisms predict the severity and response to treatment in vitamin D deficiency myopathy
69. Vitamin D receptor genotype and the risk of bone fractures in women
70. 3 in normal man and patients with renal failure
71. Effects of 1,25-Dihydroxycholecalciferol on calcium absorption, muscle weakness, and bone disease in chronic renal failure
72. Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women
73. Effect of estrogen, calcitriol and a combination of estrogen and calcitriol on bone mineral density and fractures in elderly women
74. Vitamin D therapy of osteoporosis: Plain vitamin D therapy versus active vitamin D analog (D-hormone) therapy
75. The rate of bone mineral loss in normal men and the effects of calcium and cholecalciferol supplementation
76. 3 on circulating levels of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D
77. The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly subjects
78. The role of calcitriol in the treatment of osteoporosis
79. 3 on calcium balance and bone turnover and its effect on vertebral fracture rate
80. Calcitriol in the treatment of postmenopausal osteoporosis
81. Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol: A randomized controlled study
82. Calcitriol treatment is not effective in postmenopausal osteoporosis
83. Postmenopausal osteoporosis: No effect of three years treatment with 1,25-dihydroxycholecalciferol
84. Treatment of postmenopausal osteoporosis with calcitriol or calcium
85. 3
86. 3
87. 3
88. 3 on bone mineral density and incidence of fracture: A placebo-controlled, double-blind prospective study
89. 3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis
90. Treatment with active vitamin D metabolites and concurrent treatments in the prevention of hip fractures: A retrospective study